Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,549,000 | 2,367,000 | 5,500,000 | 3,182,000 | 2,720,000 |
| Marketable Securities | 3,013,000 | 1,622,000 | 154,000 | 203,000 | 237,000 |
| Receivables | 3,660,000 | 2,968,000 | 3,992,000 | 3,662,000 | 3,272,000 |
| Inventories | 1,601,000 | 1,608,000 | 1,699,000 | 1,831,000 | 2,126,000 |
| Income taxes - deferred | 864,000 | 1,013,000 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 912,000 |
| TOTAL | $11,997,000 | $10,060,000 | $13,249,000 | $9,824,000 | $9,267,000 |
| Non-Current Assets | |||||
| PPE Net | 5,712,000 | 5,334,000 | 4,887,000 | 4,548,000 | 4,621,000 |
| Intangibles | 6,568,000 | 6,740,000 | 7,203,000 | 1,820,000 | 0 |
| Other Non-Current Assets | 3,171,000 | 2,888,000 | 2,473,000 | 1,386,000 | 3,226,000 |
| TOTAL | $15,451,000 | $14,962,000 | $14,563,000 | $7,754,000 | $7,847,000 |
| Total Assets | $27,448,000 | $25,022,000 | $27,812,000 | $17,578,000 | $17,114,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 232,000 | 1,379,000 | 174,000 | 162,000 | 0 |
| Accounts payable and accrued liabilities | 1,893,000 | 1,551,000 | 1,478,000 | 1,702,000 | 1,657,000 |
| Accrued Expenses | 2,661,000 | 2,537,000 | 3,141,000 | 3,067,000 | 2,367,000 |
| Other current liabilities | N/A | N/A | N/A | N/A | 287,000 |
| TOTAL | $7,461,000 | $8,487,000 | $11,109,000 | $5,632,000 | $5,537,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,522,000 | 6,261,000 | 6,237,000 | 1,336,000 | 1,342,000 |
| Deferred Revenues | 76,000 | 470,000 | 2,026,000 | N/A | N/A |
| aiOther Non-Current Liabilities | 1,679,000 | 1,518,000 | 1,391,000 | 1,430,000 | 1,590,000 |
| TOTAL | $10,201,000 | $7,779,000 | $7,628,000 | $2,766,000 | $2,932,000 |
| Total Liabilities | $17,662,000 | $16,266,000 | $18,737,000 | $8,398,000 | $8,469,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,941,090 | 1,937,432 | 1,936,675 | N/A | N/A |
| Common Shares | 220,000 | 220,000 | 220,000 | 220,000 | 219,000 |
| Retained earnings | 19,439,000 | 18,503,000 | 18,958,000 | 17,781,000 | 15,000,000 |
| Other shareholders' equity | -910,000 | -956,000 | -1,117,000 | -1,103,000 | -816,000 |
| TOTAL | $9,786,000 | $8,756,000 | $9,075,000 | $9,180,000 | $8,645,000 |
| Total Liabilities And Equity | $27,448,000 | $25,022,000 | $27,812,000 | $17,578,000 | $17,114,000 |